Decreased small arterial compliance with increased serum vascular endothelial growth factor-A and circulating endothelial progenitor cell in dilated cardiomyopathy

Chinese Medical Journal

Volumn 121, Issue 4, 2008, Pages 316-320

  Zhou, Yan Li ^a   Li, Xin Li ^a   Zhang, Hai Feng ^a   Yao, Wen Ming ^a   Tong, Min ^a   Xu, Qiong ^a   Cao, Ke Jiang ^a   Huang, Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Arterial compliance; Dilated cardiomyopathy; Endothelial progenitor cell; Vascular endothelial growth factor A

Indexed keywords

BIOLOGICAL MARKER; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTERY COMPLIANCE; ARTICLE; CD34 SELECTION; CELL ASSAY; CELL COUNT; CELL LINEAGE; CIRCULATION; COLONY FORMING UNIT; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION FUNCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STEM CELL; AGED; ARTERY; BLOOD; CELL MOTION; COMPLIANCE (PHYSICAL); CYTOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; ARTERIES; CARDIOMYOPATHY, DILATED; CELL MOVEMENT; COMPLIANCE; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41649112539     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200802020-00007     Document Type: Article

References (27)

1. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842.
2. Dietmar A, Reinhold H, Romana S, Roland B, Patrick P, Aurelia M, et al. Selective downregulation of VEGF-A165, VEGF-R1, and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res 2000; 87: 644-647.
3. Emma T, Jianming W, Fredrik P, Günther W. Upregulation of VEGF-A without angiogenesis in a mouse model of dilated cardiomyopathy caused by mitochondrial dysfunction. J Histochem Cytochem 2002; 50: 935-944.
4. van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM, et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Capdiol 2000; 35: 19-28.
5. Marti V, Aymat R, Ballester M, Garcia J, Carrio I, Auge JM. Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy. Int J Cardiol 2002; 82: 237-245.
6. Stolen KQ, Kemppainen J, Kalliokoski KK, Karanko H, Toikka J, Janatuinen T, et al. Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2004; 93: 64-68.
7. Lage SG, Kopel L, Monachini MC, Medeiros CJ, Pileggi F, Polak JF, et al. Carotid arterial compliance in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 74: 691-695.
8. De Boer RA, Henning RH, Tio RA, Pinto YM, Brouwer RM, Ploeg RJ, et al. Identification of a specific pattern of downregulation. in expression of isoforms of vascular endothelial growth factor in dilated cardiomyopathy. Heart 2002; 88: 412-414.
9. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Honma T, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776-2779.
10. George J, Goldstein E, Abashidze S, Deutsch V, Shmilovich H, Finkelstein A, et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 2004; 25: 1003-1008.
11. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events. Circulation 2005; 111: 2981-2987.
12. Carmen U, Stefanie D. Endothelial progenitor cells characterization and role in vascular biology. Circ Res 2004; 95: 343-353.
13. Cohn JN, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J, et al. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 1995; 26: 503-508.
14. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factor for coronary artery disease. Circ Res 2001; 89: E1-E7.
15. Sitges M, Roig E, Morales M, Azqueta M, Perez Villa F, Pare C, et al. Impaired endothelium-dependent forearm vasodilation in idiopathic dilated cardiomyopathy is related to severe left ventricular dysfunction and elevated serum tumor necrosis factor levels. Rev Esp Cardiol 2005; 58: 477-483.
16. Roura S, Planas F, Prat-Vidal C, Leta R, Soler-Botija C, Carreras F, et al. Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation. Eur J Heart Fail 2007; 9: 995-1002.
17. Mcveigh GE, Allen PB, Morgan DR, Hanratty CG, Silke B. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin Sci 2001; 100: 387-393.
18. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006; 124: 175-189.
19. Takayuki A, Tomono T, Haruchika M, Christoph K, Donghui, C, Hideki I, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972.
20. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thislethwaite PA, et al. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000; 342: 626-633.
21. Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004; 110: 2355-2360.
22. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017.
23. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422-3427.
24. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
25. + endothelial precursor cells. Circ Res 2001; 88: 167-174.
26. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, et al. CD34 and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 2004; 110: 1209-1212.
27. Duprez DA, Buyzere D, Rietzschel ER, Taes Y, Clement DL, Morgan D, et al. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. Eur Heart J 1998; 19: 1371-1376.